Case report

Increased insulin sensitivity in tumor hypoglycemia in a diabetic patient: Glucose metabolism in tumor hypoglycemia

Nir Barzilai, P. Cohen, R. Bar-Illan, N. McIntyre, E. Karnieli

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A 58-year-old man, with primary hemochromatosis, cirrhosis, and diabetes mellitus treated with insulin developed hepatoma. As the tumor grew, he lost his dependence on insulin therapy and experienced episodes of hypoglycemia. His response to infuse insulin was studied using the euglycemic clamp technique. Insulin was infused at rates of 1 and 10 μ/kg/min. The insulin dose response curve was shifted to the left and at plasma insulin levels of 72 μU/ml, steady-state glucose consumption was 9.6 mg/kg/min, 50% more than in normals, and nearly three times greater than that in other cirrhotics. The insulin clearance rate was 4417 m1/m2/min, almost five and six times more than in normals and cirrhotics, respectively. Basal hepatic glucose production was 3.6 mg/kg/min, two and three times higher than in normal and in cirrhotic subjects, respectively. The decrease in amino acid during hyperinsulinemia was more than 30% higher than in normal and other cirrhotics. IFG-I and II levels were not elevated in this patient. Increased insulin sensitivity and increased insulin clearance and serum amino acid decrease in response to insulin in vivo, suggest that insulin responsive tissues are at last partially responsible for tumor hypoglycemia. The increased glucose disposal rate probably accounted for the disappearance of the diabetes.

Original languageEnglish (US)
Pages (from-to)229-234
Number of pages6
JournalAmerican Journal of the Medical Sciences
Volume302
Issue number4
StatePublished - 1991
Externally publishedYes

Fingerprint

Hypoglycemia
Insulin Resistance
Insulin
Glucose
Neoplasms
Amino Acids
Glucose Clamp Technique
Hemochromatosis
Hyperinsulinism
Hepatocellular Carcinoma
Diabetes Mellitus
Fibrosis
Liver
Serum

Keywords

  • cirrhosis
  • Glucose
  • hepatoma
  • hypoglycemia
  • IGF-II
  • insulin
  • insulin sensitivity
  • tumor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Case report : Increased insulin sensitivity in tumor hypoglycemia in a diabetic patient: Glucose metabolism in tumor hypoglycemia. / Barzilai, Nir; Cohen, P.; Bar-Illan, R.; McIntyre, N.; Karnieli, E.

In: American Journal of the Medical Sciences, Vol. 302, No. 4, 1991, p. 229-234.

Research output: Contribution to journalArticle

@article{4513d3d3f34f44aaa4a7a7e0275b2635,
title = "Case report: Increased insulin sensitivity in tumor hypoglycemia in a diabetic patient: Glucose metabolism in tumor hypoglycemia",
abstract = "A 58-year-old man, with primary hemochromatosis, cirrhosis, and diabetes mellitus treated with insulin developed hepatoma. As the tumor grew, he lost his dependence on insulin therapy and experienced episodes of hypoglycemia. His response to infuse insulin was studied using the euglycemic clamp technique. Insulin was infused at rates of 1 and 10 μ/kg/min. The insulin dose response curve was shifted to the left and at plasma insulin levels of 72 μU/ml, steady-state glucose consumption was 9.6 mg/kg/min, 50{\%} more than in normals, and nearly three times greater than that in other cirrhotics. The insulin clearance rate was 4417 m1/m2/min, almost five and six times more than in normals and cirrhotics, respectively. Basal hepatic glucose production was 3.6 mg/kg/min, two and three times higher than in normal and in cirrhotic subjects, respectively. The decrease in amino acid during hyperinsulinemia was more than 30{\%} higher than in normal and other cirrhotics. IFG-I and II levels were not elevated in this patient. Increased insulin sensitivity and increased insulin clearance and serum amino acid decrease in response to insulin in vivo, suggest that insulin responsive tissues are at last partially responsible for tumor hypoglycemia. The increased glucose disposal rate probably accounted for the disappearance of the diabetes.",
keywords = "cirrhosis, Glucose, hepatoma, hypoglycemia, IGF-II, insulin, insulin sensitivity, tumor",
author = "Nir Barzilai and P. Cohen and R. Bar-Illan and N. McIntyre and E. Karnieli",
year = "1991",
language = "English (US)",
volume = "302",
pages = "229--234",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Case report

T2 - Increased insulin sensitivity in tumor hypoglycemia in a diabetic patient: Glucose metabolism in tumor hypoglycemia

AU - Barzilai, Nir

AU - Cohen, P.

AU - Bar-Illan, R.

AU - McIntyre, N.

AU - Karnieli, E.

PY - 1991

Y1 - 1991

N2 - A 58-year-old man, with primary hemochromatosis, cirrhosis, and diabetes mellitus treated with insulin developed hepatoma. As the tumor grew, he lost his dependence on insulin therapy and experienced episodes of hypoglycemia. His response to infuse insulin was studied using the euglycemic clamp technique. Insulin was infused at rates of 1 and 10 μ/kg/min. The insulin dose response curve was shifted to the left and at plasma insulin levels of 72 μU/ml, steady-state glucose consumption was 9.6 mg/kg/min, 50% more than in normals, and nearly three times greater than that in other cirrhotics. The insulin clearance rate was 4417 m1/m2/min, almost five and six times more than in normals and cirrhotics, respectively. Basal hepatic glucose production was 3.6 mg/kg/min, two and three times higher than in normal and in cirrhotic subjects, respectively. The decrease in amino acid during hyperinsulinemia was more than 30% higher than in normal and other cirrhotics. IFG-I and II levels were not elevated in this patient. Increased insulin sensitivity and increased insulin clearance and serum amino acid decrease in response to insulin in vivo, suggest that insulin responsive tissues are at last partially responsible for tumor hypoglycemia. The increased glucose disposal rate probably accounted for the disappearance of the diabetes.

AB - A 58-year-old man, with primary hemochromatosis, cirrhosis, and diabetes mellitus treated with insulin developed hepatoma. As the tumor grew, he lost his dependence on insulin therapy and experienced episodes of hypoglycemia. His response to infuse insulin was studied using the euglycemic clamp technique. Insulin was infused at rates of 1 and 10 μ/kg/min. The insulin dose response curve was shifted to the left and at plasma insulin levels of 72 μU/ml, steady-state glucose consumption was 9.6 mg/kg/min, 50% more than in normals, and nearly three times greater than that in other cirrhotics. The insulin clearance rate was 4417 m1/m2/min, almost five and six times more than in normals and cirrhotics, respectively. Basal hepatic glucose production was 3.6 mg/kg/min, two and three times higher than in normal and in cirrhotic subjects, respectively. The decrease in amino acid during hyperinsulinemia was more than 30% higher than in normal and other cirrhotics. IFG-I and II levels were not elevated in this patient. Increased insulin sensitivity and increased insulin clearance and serum amino acid decrease in response to insulin in vivo, suggest that insulin responsive tissues are at last partially responsible for tumor hypoglycemia. The increased glucose disposal rate probably accounted for the disappearance of the diabetes.

KW - cirrhosis

KW - Glucose

KW - hepatoma

KW - hypoglycemia

KW - IGF-II

KW - insulin

KW - insulin sensitivity

KW - tumor

UR - http://www.scopus.com/inward/record.url?scp=0025940575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025940575&partnerID=8YFLogxK

M3 - Article

VL - 302

SP - 229

EP - 234

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 4

ER -